Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease
Status:
Completed
Trial end date:
2014-09-15
Target enrollment:
Participant gender:
Summary
To provide open-label re-treatment with PROCHYMAL to subjects enrolled in companion Protocol
603 to evaluate the safety in subjects with active Crohn's disease who are resistant to
standard Crohn's disease therapies.